These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30215052)

  • 21. The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    Na SK; Choi GH; Lee HC; Shin YM; An J; Lee D; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
    PLoS One; 2018; 13(6):e0198138. PubMed ID: 29879137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined hepatocellular carcinoma and cholangiocarcinoma: a case report and review of the literature.
    Zhou YM; Yang JM; Wang B; Xu F; Tong Y; Li DQ
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):656-9. PubMed ID: 18086637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Connell LC; Harding JJ; Shia J; Abou-Alfa GK
    Chin Clin Oncol; 2016 Oct; 5(5):66. PubMed ID: 27829279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma.
    Kim M; Hwang S; Song GW; Ahn CS; Moon DB; Jung DH; Park GC; Lee SG
    Korean J Transplant; 2021 Jun; 35(2):116-123. PubMed ID: 35769525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of sarcomatoid combined hepatocellular-cholangiocarcinoma].
    Jeong BJ; Hyun DH; Lee KW; Ryu ST; Lee JW; Lee JI; Jeong S; Lee DH; Kim PS; Kim HG; Kim YS; Kim JM
    Korean J Gastroenterol; 2004 Jan; 43(1):56-60. PubMed ID: 14745254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of LINE-1 methylation level in 321 patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Miyata T; Yamashita YI; Baba Y; Harada K; Yamao T; Umezaki N; Tsukamoto M; Kitano Y; Yamamura K; Arima K; Nakagawa S; Okabe H; Imai K; Hashimoto D; Chikamoto A; Shimokawa M; Baba H
    Oncotarget; 2018 Apr; 9(29):20795-20806. PubMed ID: 29755690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
    Groeschl RT; Turaga KK; Gamblin TC
    J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological characteristics and prognostic factors in combined hepatocellular carcinoma and cholangiocarcinoma.
    Park SE; Lee SH; Yang JD; Hwang HP; Hwang SE; Yu HC; Moon WS; Cho BH
    Korean J Hepatobiliary Pancreat Surg; 2013 Nov; 17(4):152-6. PubMed ID: 26155231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy.
    Yu J; Zhang X; Huang Q; Tan S; Xiong X; Gou H
    Cancer Manag Res; 2021; 13():4283-4290. PubMed ID: 34113169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
    Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
    Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Jung DH; Hwang S; Kim KH; Hong SM; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu ES; Lee SG
    World J Surg; 2017 Mar; 41(3):825-834. PubMed ID: 27812807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma.
    Kobayashi M; Furuta K; Kitamura H; Oguchi K; Arai M; Koike S; Nakazawa K
    Clin J Gastroenterol; 2011 Aug; 4(4):236-241. PubMed ID: 26189527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series.
    De Vito C; Sarker D; Ross P; Heaton N; Quaglia A
    Virchows Arch; 2017 Nov; 471(5):619-629. PubMed ID: 28707055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome and prognostic factors of combined hepatocellular carcinoma and cholangiocarcinoma after curative resection.
    Jiang XX; Huang XT; Huang CS; Chen LH; Liang LJ; Yin XY
    Gastroenterol Rep (Oxf); 2020 Apr; 8(2):134-142. PubMed ID: 32280473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing Clonality Between Components of Combined Hepatocellular Carcinoma and Cholangiocarcinoma by Targeted Sequencing.
    Jeon J; Maeng LS; Bae YJ; Lee EJ; Yoon YC; Yoon N
    Cancer Genomics Proteomics; 2018; 15(4):291-298. PubMed ID: 29976634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT].
    Shimizu J; Hayashi S; Dono K; Yasumoto T; Zenitani M; Munakata K; Watanabe N; Takamoto K; Kagawa Y; Hata T; Kawanishi K; Ikeda K; Fujita J; Akagi K; Kitada M; Shimano T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2380-2. PubMed ID: 20037429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature.
    Hu J; Yuan R; Huang C; Shao J; Zou S; Wang K
    World J Surg Oncol; 2016 Aug; 14(1):218. PubMed ID: 27535234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Hepatic Carcinosarcoma Composed of Hepatocellular Carcinoma, Cholangiocarcinoma, Osteosarcoma and Rhabdomyosarcoma With Poor Prognosis.
    Liu LI; Ahn E; Studeman K; Campbell K; Lai J
    Anticancer Res; 2020 Apr; 40(4):2225-2229. PubMed ID: 32234918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.
    Coulouarn C; Cavard C; Rubbia-Brandt L; Audebourg A; Dumont F; Jacques S; Just PA; Clément B; Gilgenkrantz H; Perret C; Terris B
    Carcinogenesis; 2012 Sep; 33(9):1791-6. PubMed ID: 22696594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.